Ensuring Viral Vector Supply For Gene Therapies

The rapid success of gene therapies also brings with it a number of challenges, the most significant being ensuring a sufficient viral vector supply, despite shortened development timelines.

This infographic demonstrates how cells grown in suspension are much better suited for large-scale production of viral vectors, what to consider in order to successfully scale-up your viral vector production, including the challenges faced in upstream upscaling, and a specific solution we’ve developed to help you address these challenges.

Labiotech UG, All Rights Reserved. Learn more at https://www.labiotech.eu/infographics/ensuring-viral-vector-supply-gene-therapies/